These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study. Raja M; Azzoni A Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708 [TBL] [Abstract][Full Text] [Related]
4. Preventing neuroleptic-induced tardive dyskinesia in adults and children. Lam RW; Jeste SD; Jeste DV Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652 [TBL] [Abstract][Full Text] [Related]
5. Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review. D'Abreu A; Friedman JH Tremor Other Hyperkinet Mov (N Y); 2018; 8():570. PubMed ID: 30191087 [TBL] [Abstract][Full Text] [Related]
7. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223 [TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia: managing a common neuroleptic side effect. Jeste DV; Krull AJ; Kilbourn K Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304 [TBL] [Abstract][Full Text] [Related]
9. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454 [TBL] [Abstract][Full Text] [Related]